- Country: Russia
- Summary: Delivery of Drugs for a Daily Hospital (Mnn: Ethylmethylhydroxypyridine Succinate, Foreigner+Nicotinamide+Riboflavin+Amber Acid, Choline Alphascerates)
- RUT Ref No: 125104552
- Deadline: 10 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 2996993.00
- Notice Type: Tender
- Document Ref. No.: 32515153551
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Lot name:- supply of medicines for a daily hospital (MNN: ethylmethylhydroxypyridine succinate, inosin+nicotinamide+riboflavin+amber acid, choline alfoscerates)
Preparations for the treatment of diseases of the nervous system Other limitation - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDelivery of Drugs for a Daily Hospital (Mnn: Ethylmethylhydroxypyridine Succinate, Foreigner+Nicotinamide+Riboflavin+Amber Acid, Choline Alphascerates) - Russia Tender
The STATE AUTONOMOUS HEALTHCARE INSTITUTION OF THE NOVOSIBIRSK REGION CITY CLINICAL POLYCLINIC NO. 1, a Government sector organization in Russia, has announced a new tender for Delivery of Drugs for a Daily Hospital (Mnn: Ethylmethylhydroxypyridine Succinate, Foreigner+Nicotinamide+Riboflavin+Amber Acid, Choline Alphascerates). This tender is published on RussiaTenders under RUT Ref No: 125104552 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-10.
The estimated tender value is RUB 2996993.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
